@Article{ecn.2026.082748,
AUTHOR = {Ines Allam, Ouassila Madani, Brahim Belaid, Fatma Merah, Ferial Messaoui, Linda Azzoug, Abdelmalek Balamane, Reda Djidjik},
TITLE = {Assessment of T helper 17 cells/regulatory T cells balance and serum cytokine levels in patients with Crohn’s disease},
JOURNAL = {European Cytokine Network},
VOLUME = {},
YEAR = {},
NUMBER = {},
PAGES = {{pages}},
URL = {http://www.techscience.com/ECN/online/detail/27536},
ISSN = {1952-4005},
ABSTRACT = { <b>Background:</b> Crohn’s disease (CD) is a chronic inflammatory disorder resulting from the interaction between genetic susceptibility, environmental factors, intestinal microbiota, and dysregulated immune responses. Despite major advances, the precise mechanisms underlying disease development remain incompletely understood. This study aimed to evaluate the proportions of Th17 and regulatory T (Treg) cells, as well as serum cytokine levels, in the peripheral blood of patients with CD. <b>Methods:</b> We enrolled 46 patients with active CD (median age: 31.5 years) and 30 healthy subjects (median age: 30.0 years). Th17 and Treg cell populations were analyzed by flow cytometry, while serum concentrations of TNF-α, IL-1β, IL-6, IL-8, and IL-10 were measured using a chemiluminescent immunoassay. <b>Results:</b> Our results showed a significantly higher proportion of Th17 cells (3.62 ± 1.65% vs. 1.83 ± 1.00%, <i>p</i> = 0.007) and a significantly lower proportion of Treg cells (1.03 ± 0.96% vs. 2.59 ± 2.04%, <i>p</i> &lt; 0.001) in CD patients compared with healthy controls. In addition, serum levels of TNF-α, IL-1β, IL-6, and IL-8 were significantly increased in CD patients (<i>p</i> = 0.011, <i>p</i> = 0.012, <i>p</i> &lt; 0.0001, <i>p</i> &lt; 0.0001, respectively), whereas IL-10 levels did not differ significantly between the two groups (<i>p</i> &gt; 0.05). <b>Conclusion:</b> The imbalance in the Th17/Treg ratio and the elevated levels of inflammatory cytokines support the presence of an active inflammatory process in CD. These findings suggest that such immunological alterations may represent potential biomarkers of disease activity, although further validation in larger longitudinal studies, including mucosal investigations, is required.},
DOI = {10.32604/ecn.2026.082748}
}